US OptionsDetailed Quotes
PFE240726P36000
- 5.60
- -0.75-11.81%
15min DelayClose Jul 25 16:00 ET
5.70High5.60Low
5.70Open6.35Pre Close83 Volume80 Open Interest36.00Strike Price47.28KTurnover447.52%IV-0.73%PremiumJul 26, 2024Expiry Date5.82Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7826Delta0.0487Gamma4.64Leverage Ratio-1.2195Theta-0.0006Rho-3.63Eff Leverage0.0040Vega
Pfizer Stock Discussion
PFE us at resistance, 30.70
Earnings soon, stars aligned
above 50 EMA
When PFE turns, it will move hard and fast. a lot of pressure has been built up over the 1.5-year drop.
This treatment for patients with hemophilia A appears to have the efficacy and safety metrics in place to warrant a potential approval.
Notably, Sangamo’s candidate is being developed alongside $Pfizer(PFE.US)$ , adding a layer of clout to the R&D behind the prospective treatment.
Sneaking on the radar on a red day.
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful” – Warren Buffett
“Success means being very patient, but aggressive when it’s time.” – Charlie Munger
My previous posts,
I am looking forward to upcoming Fed cuts
Will Nvidia Pullback to 90 ?
$NVIDIA(NVDA.US)$ $iShares Russell 2000 ETF(IWM.US)$ $MarketAxess(MKTX.US)$ $Pfizer(PFE.US)$ $Vanguard Real Estate ETF(VNQ.US)$ $Global Payments(GPN.US)$
loading...
No comment yet